Chemiluminescence Immunoassay (CLIA) Analyzers Market Development, Analysis, Trends, Growth, Size, Share and Forecast 2022 To 2030
Market Overview
During the
projection period from 2022 to 2030, the Chemiluminescence Immunoassay
Analyzers Market Development. The two primary reasons driving this market's rise are the increased
need for automated chemiluminescence immunoassays and the rising number of
clinical trials in emerging nations.
Chemiluminescence
An immunoassay analyzer detects the amount of antigen or antibody present in
serum, blood, or urine samples. It detects and quantifies antigens or
antibodies using light from excited molecules. Because no specific training is
required, the tests are quick and simple to complete. The chemiluminescence
immunoassay analyzer's technique is based on the idea of luminescence.
Fluorescent compounds, such as acridinium esters and luciferins, are used as
the light source in this approach. These devices emit Short-wave ultraviolet
(UV) light. The Chemiluminescence Immunoassay Analyzer is precise, dependable,
and quick. It can detect single target molecules in a very short time, even at
very low concentrations. An enzyme-linked assay can also be performed using the
chemiluminescent reaction and radioimmunoassay (RIA).
The Chemiluminescence Immunoassay (CLIA) Analyzers
Market CAGR 7.3% and is anticipated to reach USD 12.35 billion during the
forecast period 2022-2030
Major key players
There are many prominent Key
Chemiluminescence Immunoassay Analyzers Market Players. Among all the key
players investing in the market, here is the list of most prominent ones-
Abbott, Hoffmann-La Roche Ltd, Siemens Healthcare GmbH
(Siemens AG), Danaher (Beckman Coulter, Inc.), DiaSorin S.p.A., Ortho Clinical
Diagnostics (Part of Carlyle Group), Shenzhen New Industries Biomedical
Engineering Co., Ltd., Sysmex Corporation, Randox Laboratories Ltd., Tosoh
Corporation, Others
Market Segmentation
By Type
The Chemiluminescence Immunoassay (CLIA)
Analyzers Market is further divided based on type into:
●
Medium
Throughput
●
High
Throughput
●
Low
Throughput
By Product
The Chemiluminescence Immunoassay (CLIA)
Analyzers Market is further divided based on type into:
●
Reagents
●
Luminophore
Markers
●
Enzymatic
Markers
●
Analyzer
●
Semi-automated
●
Consumables
●
Automated
By Application
The Chemiluminescence Immunoassay (CLIA)
Analyzers Market is further divided based on type into:
●
Oncology
& Endocrinology
●
Cardiac
Markers
●
Hepatitis
and Retroviruses
●
Infectious
Disease
●
Auto-Immune
Diseases
●
Bone
and Mineral Disorders
●
Allergy
●
Drug
Discovery and Development
●
GI
Stool Testing
●
Others
By End-User
The Chemiluminescence Immunoassay (CLIA)
Analyzers Market is further divided based on type into:
●
Hospitals
& Clinics
●
Pharmaceutical
& Biotechnology Industries
●
Medical
& Diagnostic Laboratories
●
Others
Regional Classification
The market
is divided into five regions: North America, Asia Pacific, Latin America,
Europe, the Middle East, and Africa. North America is expected to dominate the
market during the projected period, with the highest CAGR. During the
projection period, Latin America is anticipated to witness the fastest market
for chemiluminescence immunoassay analyzers. The second-largest market share is
expected to be held by Europe. Asia Pacific is predicted to be the
second-fastest-growing market for chemiluminescence immunoassay analyzers
during the projection period. Chemiluminescence immunoassay analyzers have the
smallest market in the Middle East and Africa.
Industry News
The number
of tests that use Chemiluminescence Immunoassay Analyzers (CLIA) techniques is
expected to grow due to technological advancements in illness detection and
increased demand for preventive diagnosis and treatment monitoring.
As a
result, demand for high-throughput systems is increasing. Furthermore, by
adopting CLIA approaches, large-scale laboratories capture a larger portion of
the market by exploiting the quality and service limits experienced by small
and mid-volume laboratories.
International
corporations in the clinical labs' category increase their footprint in new
areas through acquisitions and mergers. As laboratories consolidate, test
volumes increase, resulting in a rise in comprehensive laboratory automation
and integration adoption.
The rising
occurrence of chronic diseases like cancer is due to rapid dietary habits and
lifestyle changes. As a result, the rising prevalence of acute and chronic
disorders is propelling the market.
Related Report-
http://www.barberlife.com/read-blog/107147
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment